Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Xellia Pharmaceuticals

www.xellia.com Xellia Pharmaceuticals

Dalslandsgade 11
2300 Copenhagen S
Denmark

+45 3624 5500

Related Companies

  • Bormioli Pharma
  • Gerresheimer
  • Romaco Holding GmbH
  • Copley Scientific
  • Lonza
  • Intelsius
  • Titan Enterprises
  • Icrom SRL
  • TrakCel
  • Huber
  • Autoscribe
  • Nanoform
  • GEA Pharma and Healthcare
  • Shimadzu UK
  • Merck Life Science KGaA
  • SGS Health Sciences
  • Starlab
  • Adare Pharma Solutions
  • SCIEX
  • Beamex

Related Content

Xellia Cleveland manufacturing facility operational for anti-infectives
Xellia Cleveland manufacturing facility operational for anti-infectives
Xellia Pharmaceuticals launches additional Vanco Ready doses
Xellia Pharmaceuticals launches additional Vanco Ready doses
Xellia Pharmaceuticals expands approved doses of VANCO READYTM
Xellia Pharmaceuticals expands approved doses of VANCO READYTM
Career Opportunities: Automation Engineer (7243)
Career Opportunities: Automation Engineer (7243)
Career Opportunities: Global Packaging Manager, Sterile Products (5677)
Career Opportunities: Global Packaging Manager, Sterile Products (5677)
Career Opportunities: Senior Logistics and Process Engineer (6982)
Career Opportunities: Senior Logistics and Process Engineer (6982)
Career Opportunities: Sr Scientist, On Market Products (5942)
Career Opportunities: Sr Scientist, On Market Products (5942)
Career Opportunities: Compliance Quality Assurance Specialist (5667)
Career Opportunities: Compliance Quality Assurance Specialist (5667)
Xellia Pharmaceuticals reports strong year for 2019 and key business updates
Xellia Pharmaceuticals reports strong year for 2019 and key business updates
FDA approves Xellia US facility for CMO injectables
FDA approves Xellia US facility for CMO injectables
Xellia divests North Carolina production facilities to Sagent Pharmaceuticals
Xellia divests North Carolina production facilities to Sagent Pharmaceuticals
Xellia Pharmaceuticals appoints Matthew Anderson as CFO
Xellia Pharmaceuticals appoints Matthew Anderson as CFO
Xellia Pharmaceuticals appoints Craig Boyd as President of Xellia US
Xellia Pharmaceuticals appoints Craig Boyd as President of Xellia US
Xellia Pharmaceuticals expands with US$25m investment in Copenhagen
Xellia Pharmaceuticals expands with US$25m investment in Copenhagen
Xellia Pharmaceuticals signs Davos Declaration on 
combating Antimicrobial Resistance
Xellia Pharmaceuticals signs Davos Declaration on 
combating Antimicrobial Resistance
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company